chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure decreased, Cardiac flutter, Heart rate increased
Clinical narrative: heart flutter; Fast heart rate; some low blood pressure incidents; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient). A 51-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6205 and expiration date was not reported), second dose via an unspecified route of administration, administered in arm left on 08Mar2021 13:00 (at the age of 51 years) single for covid-19 immunisation. Medical history included drug hypersensitivity of known allergies that is Sulfa from an unknown date and unknown if ongoing. Concomitant medication(s) included fluticasone, azelastine, pseudoephedrine hydrochloride (SUDAFED 12 HOUR), cholecalciferol (VIT D3) taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior vaccination and since the vaccination. Historical Vaccine received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EM9809 and expiration date was not reported), first dose via an unspecified route of administration, administered in right arm on 15Feb2021 15:30 single for covid-19 immunisation. On 17Mar2021 14:00 the patient experienced fast heart rate, flutter, some low blood pressure incidents. The outcome of the events was unknown.  Information on Lot/Batch number was available. Additional information has been requested.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardiac flutter, Heart rate increased, Hypotension
Clinical narrative: heart flutter; Fast heart rate; some low blood pressure incidents; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient). A 51-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6205 and expiration date was not reported), second dose via an unspecified route of administration, administered in arm left on 08Mar2021 13:00 (at the age of 51 years) single for covid-19 immunisation. Medical history included drug hypersensitivity of known allergies that is Sulfa from an unknown date and unknown if ongoing. Concomitant medication(s) included fluticasone, azelastine, pseudoephedrine hydrochloride (SUDAFED 12 HOUR), cholecalciferol (VIT D3) taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior vaccination and since the vaccination. Historical Vaccine received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EM9809 and expiration date was not reported), first dose via an unspecified route of administration, administered in right arm on 15Feb2021 15:30 single for covid-19 immunisation. On 17Mar2021 14:00 the patient experienced fast heart rate, flutter, some low blood pressure incidents. The outcome of the events was unknown.  Information on Lot/Batch number was available. Additional information has been requested.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Injection site pain, Somnolence
Clinical narrative: Extreme fatigue; Extreme pain and soreness at the injection site. I had a terrible time sleeping. It radiated into my shoulder; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EN6205), administered in left arm on 03Mar2021 (at the age of 66 years) as a single dose for COVID-19 immunisation. Medical history included basal cell carcinoma. The patient previously received hydrocodone (MANUFACTURER UNKNOWN) and oxycodone (MANUFACTURER UNKNOWN) for unspecified indication and experienced drug allergy. Concomitant medications included vitamin D 2000 IU (MANUFACTURER UNKNOWN), methyl B 1000 mcg (MANUFACTURER UNKNOWN) for an unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 03Mar2021, after the vaccination, the patient experienced no adverse effects during the day time after injection. But that evening, after the patient went to bed, the patient was woken up by extreme pain and soreness at the injection site. The patient had a terrible time sleeping. It radiated into the shoulder and lasted for four days. The patient did not sleep well at all the entire time and was affected by the pain during the day as well. The patient also experienced extreme fatigue on 04Mar2021, the next day after the vaccination but that only lasted for that day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the adverse events. The clinical outcome of the event injection site pain recovered on 07Mar2021 (after 4 days) and extreme fatigue recovered on 04Mar2021 at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Extreme fatigue; Extreme pain and soreness at the injection site. I had a terrible time sleeping. It radiated into my shoulder; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EN6205), administered in left arm on 03Mar2021 (at the age of 66 years) as a single dose for COVID-19 immunisation. Medical history included basal cell carcinoma. The patient previously received hydrocodone (MANUFACTURER UNKNOWN) and oxycodone (MANUFACTURER UNKNOWN) for unspecified indication and experienced drug allergy. Concomitant medications included vitamin D 2000 IU (MANUFACTURER UNKNOWN), methyl B 1000 mcg (MANUFACTURER UNKNOWN) for an unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 03Mar2021, after the vaccination, the patient experienced no adverse effects during the day time after injection. But that evening, after the patient went to bed, the patient was woken up by extreme pain and soreness at the injection site. The patient had a terrible time sleeping. It radiated into the shoulder and lasted for four days. The patient did not sleep well at all the entire time and was affected by the pain during the day as well. The patient also experienced extreme fatigue on 04Mar2021, the next day after the vaccination but that only lasted for that day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the adverse events. The clinical outcome of the event injection site pain recovered on 07Mar2021 (after 4 days) and extreme fatigue recovered on 04Mar2021 at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Ear discomfort, Tinnitus, Vertigo
Clinical narrative: nausea; DIZZINESS; Decreased hearing; persistenttinnitus; This is a spontaneous report from a contactable physician. A 54-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP7534) via an intramuscular route of administration in the left arm on 15March2021, as a single dose for COVID-19 immunisation (at the age of 54-years-old). Medical history included osteoarthritis of knees from an unknown date. The patient was allergic to animal dander. It was unknown whether patient received any other vaccines within four weeks prior to the vaccination. It was unknown whether prior to vaccination, patient was diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 16March2021, the patient experienced events of nausea, dizziness, decreased hearing and persistent tinnitus that remained for weeks after the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Treatment was received for adverse events which included SUDAFED and AFRIN. The clinical outcome of events nausea, dizziness, decreased hearing and persistent tinnitus was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ear discomfort, Nausea, Tinnitus, Vertigo
Clinical narrative: nausea; DIZZINESS; Decreased hearing; persistenttinnitus; This is a spontaneous report from a contactable physician. A 54-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP7534) via an intramuscular route of administration in the left arm on 15March2021, as a single dose for COVID-19 immunisation (at the age of 54-years-old). Medical history included osteoarthritis of knees from an unknown date. The patient was allergic to animal dander. It was unknown whether patient received any other vaccines within four weeks prior to the vaccination. It was unknown whether prior to vaccination, patient was diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 16March2021, the patient experienced events of nausea, dizziness, decreased hearing and persistent tinnitus that remained for weeks after the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Treatment was received for adverse events which included SUDAFED and AFRIN. The clinical outcome of events nausea, dizziness, decreased hearing and persistent tinnitus was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Hypoacusis, Nausea, Tinnitus
Clinical narrative: nausea; DIZZINESS; Decreased hearing; persistenttinnitus; This is a spontaneous report from a contactable physician. A 54-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP7534) via an intramuscular route of administration in the left arm on 15March2021, as a single dose for COVID-19 immunisation (at the age of 54-years-old). Medical history included osteoarthritis of knees from an unknown date. The patient was allergic to animal dander. It was unknown whether patient received any other vaccines within four weeks prior to the vaccination. It was unknown whether prior to vaccination, patient was diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 16March2021, the patient experienced events of nausea, dizziness, decreased hearing and persistent tinnitus that remained for weeks after the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Treatment was received for adverse events which included SUDAFED and AFRIN. The clinical outcome of events nausea, dizziness, decreased hearing and persistent tinnitus was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling face
Clinical narrative: Face swelling. Starting eyelid/around eyes most obvious.; Face swelling. Starting eyelid/around eyes most obvious.; Face swelling. Starting eyelid/around eyes most obvious.; Whole face itchy/burning sensation; Whole face itchy/burning sensation; This is a spontaneous report from a consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EL3247) via an unspecified route of administration in the left arm on 04Mar2021 at 13:15(at the age of 46-year-old) as single dose for COVID 19 immunisation. The patient medical history included swelling face on unknown date in Jul2020 and Aug2020. The patient did not take any concomitant medication. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccination. Any allergies to medications, food, or other products was reported as shellfish and cats. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination. On 07Mar2021at 19:00, the patient experienced swelling face, starting eyelid and around eyes most obvious, Whole face itchy and burning sensation. Therapeutic measures were taken as a result of the reported events and included treatment with antihistamine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care however the patient contacted her Doctor with pictures via email.  The clinical outcome of the swelling face, eye swelling, swelling of eyelids, itchy face and burning sensation was resolving. No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Eye swelling, Pruritus, Swelling face, Swelling of eyelid
Clinical narrative: Face swelling. Starting eyelid/around eyes most obvious.; Face swelling. Starting eyelid/around eyes most obvious.; Face swelling. Starting eyelid/around eyes most obvious.; Whole face itchy/burning sensation; Whole face itchy/burning sensation; This is a spontaneous report from a consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EL3247) via an unspecified route of administration in the left arm on 04Mar2021 at 13:15(at the age of 46-year-old) as single dose for COVID 19 immunisation. The patient medical history included swelling face on unknown date in Jul2020 and Aug2020. The patient did not take any concomitant medication. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccination. Any allergies to medications, food, or other products was reported as shellfish and cats. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination. On 07Mar2021at 19:00, the patient experienced swelling face, starting eyelid and around eyes most obvious, Whole face itchy and burning sensation. Therapeutic measures were taken as a result of the reported events and included treatment with antihistamine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care however the patient contacted her Doctor with pictures via email.  The clinical outcome of the swelling face, eye swelling, swelling of eyelids, itchy face and burning sensation was resolving. No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Nausea, Pain
Clinical narrative: tachycardia; nausea; This is a spontaneous report received from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733), via an unspecified route of administration in the left arm on 23Mar2021 at 12:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included low white blood cells, methylenetetrahydrofolate deficiency (MTHFR), deep vein thrombosis, leaky heart value (regurgitation) and reynauds. The patient had a leaky heart valve but not had complications or symptoms in about 2 to 3 years. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks prior to the COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021 at 18:00, the patient experienced tachycardia event while sitting still with a normal resting heart rate (RHR) about six hours after injection. Heart rate was elevated for approximately 30 min peaking at 108 (RHR was 65) (unit unspecified). It was reported that patient was awakened in the middle of the night with extreme nausea. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tachycardia and nausea was resolved on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate, Nausea, Tachycardia
Clinical narrative: tachycardia; nausea; This is a spontaneous report received from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733), via an unspecified route of administration in the left arm on 23Mar2021 at 12:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included low white blood cells, methylenetetrahydrofolate deficiency (MTHFR), deep vein thrombosis, leaky heart value (regurgitation) and reynauds. The patient had a leaky heart valve but not had complications or symptoms in about 2 to 3 years. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks prior to the COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021 at 18:00, the patient experienced tachycardia event while sitting still with a normal resting heart rate (RHR) about six hours after injection. Heart rate was elevated for approximately 30 min peaking at 108 (RHR was 65) (unit unspecified). It was reported that patient was awakened in the middle of the night with extreme nausea. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tachycardia and nausea was resolved on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Ear swelling, Feeling hot, Swelling face
Clinical narrative: having a feeling of fullness on my face; slightly warm ears for maybe 30 seconds; had a very bad feeling of sinking as l am going to die; This is a spontaneous report received from a contactable consumer, the patient. A 47-years-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in right arm on 16Mar2021 at 12:15, (at the age of 47-years-old) as a single dose, for COVID-19 immunisation. The medical history included hypothyroidism, from unknown date. The patients allergies included penicillin and MOTRIN. The patient received levothyroxine (MANUFACTURER UNKNOWN) 112mcg, for an unknown indication, from an unknown date, within two weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 16Mar2021 at 13:00, 30 minutes after the vaccination, the patient experienced a feeling of fullness on her face and slightly warm ears for maybe 30 seconds and immediately after, she had a very bad feeling of sinking as she was going to die. But in about 30 seconds she was completely alright on 16Mar2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of feeling of fullness on her face, slightly warm ears and bad feeling of sinking as she was going to die was recovered on 16Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Facial discomfort, Feeling abnormal, Skin warm
Clinical narrative: having a feeling of fullness on my face; slightly warm ears for maybe 30 seconds; had a very bad feeling of sinking as l am going to die; This is a spontaneous report received from a contactable consumer, the patient. A 47-years-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in right arm on 16Mar2021 at 12:15, (at the age of 47-years-old) as a single dose, for COVID-19 immunisation. The medical history included hypothyroidism, from unknown date. The patients allergies included penicillin and MOTRIN. The patient received levothyroxine (MANUFACTURER UNKNOWN) 112mcg, for an unknown indication, from an unknown date, within two weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 16Mar2021 at 13:00, 30 minutes after the vaccination, the patient experienced a feeling of fullness on her face and slightly warm ears for maybe 30 seconds and immediately after, she had a very bad feeling of sinking as she was going to die. But in about 30 seconds she was completely alright on 16Mar2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of feeling of fullness on her face, slightly warm ears and bad feeling of sinking as she was going to die was recovered on 16Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Throat tightness
Clinical narrative: Itchy body 24 hours after vaccine; Tight throat an hour after covid 19 vaccine; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: EN6198) via an unspecified route of administration in the left arm on 09Mar2021 at 18:15 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included sinusitis. It was also reported that the patient was allergic to penicillin, sulfa drugs (sulfonamide drugs), walnuts and bee stings. The patient did not receive any medicine within two weeks to the COVID-19 vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On an unspecified date in 2021, the patient underwent lab test color COVID-19 test (nasal swab) and resulted negative. Since the vaccination, the patient had been tested positive for COVID-19. On 09Mar2021 at 19:30, patient experienced tight throat an hour after COVID-19 vaccine and it lasted 14 days. On 10Mar2021, the patient experienced itchy body after 24 hours of vaccine and it lasted 14 days. The patient did not receive any treatment for the adverse event. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of wheezing was recovering at the time of this report. The clinical outcome of the events tight throat was recovered on 23Mar2021 and itchy body was recovered on 24Mar2021.                  No follow-up attempts possible. No further information expected.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Throat tightness, Viral test
Clinical narrative: Itchy body 24 hours after vaccine; Tight throat an hour after covid 19 vaccine; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: EN6198) via an unspecified route of administration in the left arm on 09Mar2021 at 18:15 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included sinusitis. It was also reported that the patient was allergic to penicillin, sulfa drugs (sulfonamide drugs), walnuts and bee stings. The patient did not receive any medicine within two weeks to the COVID-19 vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On an unspecified date in 2021, the patient underwent lab test color COVID-19 test (nasal swab) and resulted negative. Since the vaccination, the patient had been tested positive for COVID-19. On 09Mar2021 at 19:30, patient experienced tight throat an hour after COVID-19 vaccine and it lasted 14 days. On 10Mar2021, the patient experienced itchy body after 24 hours of vaccine and it lasted 14 days. The patient did not receive any treatment for the adverse event. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of wheezing was recovering at the time of this report. The clinical outcome of the events tight throat was recovered on 23Mar2021 and itchy body was recovered on 24Mar2021.                  No follow-up attempts possible. No further information expected.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Hypoaesthesia
Clinical narrative: Numbness, burning and pain sensitiveness in palms and fingers; Numbness, burning and painsenstiveness in palms and fingers; Numbness, burning and pain senstiveness in palms and fingers; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the left arm on 04Mar2021 at 18:00 (at the age of 60-years-old), as a single dose for Covid-19 immunisation. Medical history included blood pressure and psoriasis. The patient had a history of allergy to sulpha drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Mar2021, the patient had experienced numbness, burning and pain sensitiveness in palms and fingers. The patient received Neurontin as a part of treatment for the reported events. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events numbness, burning and pain sensitiveness in palms and fingers was not resolved at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Hyperaesthesia, Hypoaesthesia
Clinical narrative: Numbness, burning and pain sensitiveness in palms and fingers; Numbness, burning and painsenstiveness in palms and fingers; Numbness, burning and pain senstiveness in palms and fingers; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the left arm on 04Mar2021 at 18:00 (at the age of 60-years-old), as a single dose for Covid-19 immunisation. Medical history included blood pressure and psoriasis. The patient had a history of allergy to sulpha drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Mar2021, the patient had experienced numbness, burning and pain sensitiveness in palms and fingers. The patient received Neurontin as a part of treatment for the reported events. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events numbness, burning and pain sensitiveness in palms and fingers was not resolved at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema
Clinical narrative: Injection site sore for over 48 hours; Large red spot at injection site (baseball sized); Mild itching at injection site; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 2613) via an unspecified route of administration in left arm on 22Mar2021 at 12:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included ulcerative colitis. The patient had allergies to sulfa, morphine and flagyl. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 6200) via an unspecified route of administration in left arm on 01Mar2021 at 13:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any medication within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On 22Mar2021 at 14:00, the patient had Injection site sore for over 48 hours, large red spot at injection site (baseball sized) and mild itching at injection site. The red spot was the size of a quarter on day 1 but by day 3 had grown to the size of a baseball. The events had not resulted in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of injection site sore (vaccination site pain), large red spot at injection site (vaccination site erythema) and mild itching at injection site (vaccination site pruritis) was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Injection site sore for over 48 hours; Large red spot at injection site (baseball sized); Mild itching at injection site; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 2613) via an unspecified route of administration in left arm on 22Mar2021 at 12:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included ulcerative colitis. The patient had allergies to sulfa, morphine and flagyl. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 6200) via an unspecified route of administration in left arm on 01Mar2021 at 13:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any medication within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On 22Mar2021 at 14:00, the patient had Injection site sore for over 48 hours, large red spot at injection site (baseball sized) and mild itching at injection site. The red spot was the size of a quarter on day 1 but by day 3 had grown to the size of a baseball. The events had not resulted in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of injection site sore (vaccination site pain), large red spot at injection site (vaccination site erythema) and mild itching at injection site (vaccination site pruritis) was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Condition aggravated, Diarrhoea, Dizziness, Exercise tolerance decreased
Clinical narrative: face/hand sensation/Tingling; Elevated tinnitus; Night sweats; Sweats; light-headed; Vertigo; Dizzy; Nausea; vomiting; diarrhea; hands sizzling; chills; Tinnitus/Tinnitus in other ear; This is a spontaneous report from a contactable consumer (patient) reported in response to Non-HCP letter sent in cross referenced case.   A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EP7533, Expiration Date: not reported) via intramuscular, administered in left arm on 05Apr2021 at 13:00 as dose 2, single for COVID-19 immunization. Prior vaccination within 4 weeks was none. Medical history included vitamin d deficiency, dry eye, and Injury. Concomitant medication included vitamin d [vitamin d nos] taken for vitamin d deficiency and ciclosporin (RESTASIS) taken for dry eye. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection) on 08Mar2021 at 13:00, and experienced vertigo, dizzy, hearing loss, tinnitus, nauseous, diarrhea, chills, sweating, Hands felt like vibrating, and vomiting. The patient experienced vertigo, dizzy, nausea, vomiting, diarrhea, hands sizzling, chills and tinnitus/tinnitus in another ear on 05Apr2021 at 14:00. On 10Apr2021, the patient experienced light-headed. On 15Apr2021, the patient experienced sweats and on 19Apr2021, night sweats. Elevated tinnitus on 20Apr2021, face/hand sensation/tingling on 24Apr2021. The patient underwent lab tests and procedures which included blood test: all else normal, eosinophil count: low Eosinophil absolute- low, full blood count: normal, lymphocyte count: low and neutrophil count: high on 05Apr2021. The events recovered but reoccurred again. The patient did not received treatment for the events. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, Tinnitus, Tremor, Vertigo, Vomiting
Clinical narrative: face/hand sensation/Tingling; Elevated tinnitus; Night sweats; Sweats; light-headed; Vertigo; Dizzy; Nausea; vomiting; diarrhea; hands sizzling; chills; Tinnitus/Tinnitus in other ear; This is a spontaneous report from a contactable consumer (patient) reported in response to Non-HCP letter sent in cross referenced case.   A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EP7533, Expiration Date: not reported) via intramuscular, administered in left arm on 05Apr2021 at 13:00 as dose 2, single for COVID-19 immunization. Prior vaccination within 4 weeks was none. Medical history included vitamin d deficiency, dry eye, and Injury. Concomitant medication included vitamin d [vitamin d nos] taken for vitamin d deficiency and ciclosporin (RESTASIS) taken for dry eye. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection) on 08Mar2021 at 13:00, and experienced vertigo, dizzy, hearing loss, tinnitus, nauseous, diarrhea, chills, sweating, Hands felt like vibrating, and vomiting. The patient experienced vertigo, dizzy, nausea, vomiting, diarrhea, hands sizzling, chills and tinnitus/tinnitus in another ear on 05Apr2021 at 14:00. On 10Apr2021, the patient experienced light-headed. On 15Apr2021, the patient experienced sweats and on 19Apr2021, night sweats. Elevated tinnitus on 20Apr2021, face/hand sensation/tingling on 24Apr2021. The patient underwent lab tests and procedures which included blood test: all else normal, eosinophil count: low Eosinophil absolute- low, full blood count: normal, lymphocyte count: low and neutrophil count: high on 05Apr2021. The events recovered but reoccurred again. The patient did not received treatment for the events. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Deafness, Diarrhoea, Dizziness, Nausea
Clinical narrative: face/hand sensation/Tingling; Elevated tinnitus; Night sweats; Sweats; light-headed; Vertigo; Dizzy; Nausea; vomiting; diarrhea; hands sizzling; chills; Tinnitus/Tinnitus in other ear; This is a spontaneous report from a contactable consumer (patient) reported in response to Non-HCP letter sent in cross referenced case.   A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EP7533, Expiration Date: not reported) via intramuscular, administered in left arm on 05Apr2021 at 13:00 as dose 2, single for COVID-19 immunization. Prior vaccination within 4 weeks was none. Medical history included vitamin d deficiency, dry eye, and Injury. Concomitant medication included vitamin d [vitamin d nos] taken for vitamin d deficiency and ciclosporin (RESTASIS) taken for dry eye. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection) on 08Mar2021 at 13:00, and experienced vertigo, dizzy, hearing loss, tinnitus, nauseous, diarrhea, chills, sweating, Hands felt like vibrating, and vomiting. The patient experienced vertigo, dizzy, nausea, vomiting, diarrhea, hands sizzling, chills and tinnitus/tinnitus in another ear on 05Apr2021 at 14:00. On 10Apr2021, the patient experienced light-headed. On 15Apr2021, the patient experienced sweats and on 19Apr2021, night sweats. Elevated tinnitus on 20Apr2021, face/hand sensation/tingling on 24Apr2021. The patient underwent lab tests and procedures which included blood test: all else normal, eosinophil count: low Eosinophil absolute- low, full blood count: normal, lymphocyte count: low and neutrophil count: high on 05Apr2021. The events recovered but reoccurred again. The patient did not received treatment for the events. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tinnitus, Tremor, Vertigo, Vomiting
Clinical narrative: face/hand sensation/Tingling; Elevated tinnitus; Night sweats; Sweats; light-headed; Vertigo; Dizzy; Nausea; vomiting; diarrhea; hands sizzling; chills; Tinnitus/Tinnitus in other ear; This is a spontaneous report from a contactable consumer (patient) reported in response to Non-HCP letter sent in cross referenced case.   A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EP7533, Expiration Date: not reported) via intramuscular, administered in left arm on 05Apr2021 at 13:00 as dose 2, single for COVID-19 immunization. Prior vaccination within 4 weeks was none. Medical history included vitamin d deficiency, dry eye, and Injury. Concomitant medication included vitamin d [vitamin d nos] taken for vitamin d deficiency and ciclosporin (RESTASIS) taken for dry eye. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection) on 08Mar2021 at 13:00, and experienced vertigo, dizzy, hearing loss, tinnitus, nauseous, diarrhea, chills, sweating, Hands felt like vibrating, and vomiting. The patient experienced vertigo, dizzy, nausea, vomiting, diarrhea, hands sizzling, chills and tinnitus/tinnitus in another ear on 05Apr2021 at 14:00. On 10Apr2021, the patient experienced light-headed. On 15Apr2021, the patient experienced sweats and on 19Apr2021, night sweats. Elevated tinnitus on 20Apr2021, face/hand sensation/tingling on 24Apr2021. The patient underwent lab tests and procedures which included blood test: all else normal, eosinophil count: low Eosinophil absolute- low, full blood count: normal, lymphocyte count: low and neutrophil count: high on 05Apr2021. The events recovered but reoccurred again. The patient did not received treatment for the events. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Chills, Diarrhoea, Dizziness, Eosinophil count
Clinical narrative: face/hand sensation/Tingling; Elevated tinnitus; Night sweats; Sweats; light-headed; Vertigo; Dizzy; Nausea; vomiting; diarrhea; hands sizzling; chills; Tinnitus/Tinnitus in other ear; This is a spontaneous report from a contactable consumer (patient) reported in response to Non-HCP letter sent in cross referenced case.   A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EP7533, Expiration Date: not reported) via intramuscular, administered in left arm on 05Apr2021 at 13:00 as dose 2, single for COVID-19 immunization. Prior vaccination within 4 weeks was none. Medical history included vitamin d deficiency, dry eye, and Injury. Concomitant medication included vitamin d [vitamin d nos] taken for vitamin d deficiency and ciclosporin (RESTASIS) taken for dry eye. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection) on 08Mar2021 at 13:00, and experienced vertigo, dizzy, hearing loss, tinnitus, nauseous, diarrhea, chills, sweating, Hands felt like vibrating, and vomiting. The patient experienced vertigo, dizzy, nausea, vomiting, diarrhea, hands sizzling, chills and tinnitus/tinnitus in another ear on 05Apr2021 at 14:00. On 10Apr2021, the patient experienced light-headed. On 15Apr2021, the patient experienced sweats and on 19Apr2021, night sweats. Elevated tinnitus on 20Apr2021, face/hand sensation/tingling on 24Apr2021. The patient underwent lab tests and procedures which included blood test: all else normal, eosinophil count: low Eosinophil absolute- low, full blood count: normal, lymphocyte count: low and neutrophil count: high on 05Apr2021. The events recovered but reoccurred again. The patient did not received treatment for the events. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Full blood count, Hyperhidrosis, Lymphocyte count, Nausea, Neutrophil count
Clinical narrative: face/hand sensation/Tingling; Elevated tinnitus; Night sweats; Sweats; light-headed; Vertigo; Dizzy; Nausea; vomiting; diarrhea; hands sizzling; chills; Tinnitus/Tinnitus in other ear; This is a spontaneous report from a contactable consumer (patient) reported in response to Non-HCP letter sent in cross referenced case.   A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EP7533, Expiration Date: not reported) via intramuscular, administered in left arm on 05Apr2021 at 13:00 as dose 2, single for COVID-19 immunization. Prior vaccination within 4 weeks was none. Medical history included vitamin d deficiency, dry eye, and Injury. Concomitant medication included vitamin d [vitamin d nos] taken for vitamin d deficiency and ciclosporin (RESTASIS) taken for dry eye. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection) on 08Mar2021 at 13:00, and experienced vertigo, dizzy, hearing loss, tinnitus, nauseous, diarrhea, chills, sweating, Hands felt like vibrating, and vomiting. The patient experienced vertigo, dizzy, nausea, vomiting, diarrhea, hands sizzling, chills and tinnitus/tinnitus in another ear on 05Apr2021 at 14:00. On 10Apr2021, the patient experienced light-headed. On 15Apr2021, the patient experienced sweats and on 19Apr2021, night sweats. Elevated tinnitus on 20Apr2021, face/hand sensation/tingling on 24Apr2021. The patient underwent lab tests and procedures which included blood test: all else normal, eosinophil count: low Eosinophil absolute- low, full blood count: normal, lymphocyte count: low and neutrophil count: high on 05Apr2021. The events recovered but reoccurred again. The patient did not received treatment for the events. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Night sweats, Paraesthesia, Tinnitus, Tremor, Vertigo
Clinical narrative: face/hand sensation/Tingling; Elevated tinnitus; Night sweats; Sweats; light-headed; Vertigo; Dizzy; Nausea; vomiting; diarrhea; hands sizzling; chills; Tinnitus/Tinnitus in other ear; This is a spontaneous report from a contactable consumer (patient) reported in response to Non-HCP letter sent in cross referenced case.   A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EP7533, Expiration Date: not reported) via intramuscular, administered in left arm on 05Apr2021 at 13:00 as dose 2, single for COVID-19 immunization. Prior vaccination within 4 weeks was none. Medical history included vitamin d deficiency, dry eye, and Injury. Concomitant medication included vitamin d [vitamin d nos] taken for vitamin d deficiency and ciclosporin (RESTASIS) taken for dry eye. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection) on 08Mar2021 at 13:00, and experienced vertigo, dizzy, hearing loss, tinnitus, nauseous, diarrhea, chills, sweating, Hands felt like vibrating, and vomiting. The patient experienced vertigo, dizzy, nausea, vomiting, diarrhea, hands sizzling, chills and tinnitus/tinnitus in another ear on 05Apr2021 at 14:00. On 10Apr2021, the patient experienced light-headed. On 15Apr2021, the patient experienced sweats and on 19Apr2021, night sweats. Elevated tinnitus on 20Apr2021, face/hand sensation/tingling on 24Apr2021. The patient underwent lab tests and procedures which included blood test: all else normal, eosinophil count: low Eosinophil absolute- low, full blood count: normal, lymphocyte count: low and neutrophil count: high on 05Apr2021. The events recovered but reoccurred again. The patient did not received treatment for the events. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.